INDBInternet News Database 2.5 Updated 2 min ago · 393 sources Show or hide images Light or dark

FDA Approves First Treatment for Neurologic Symptoms of Type 3 Gaucher Disease

Save Like Comments Compare coverage
Image from Medpagetoday

Summary

(MedPage Today) -- The FDA approved venglustat (Infilbray) tablets as the first treatment for neurologic symptoms of type 3 Gaucher disease in adults and children weighing at least 15 kg, the agency announced Wednesday. Gaucher disease is a rare...

Description from Medpagetoday.

Who is covering this

  1. Medpagetoday Center Factuality: Mostly factual US
    FDA Approves First Treatment for Neurologic Symptoms of Type 3 Gaucher Disease

    (MedPage Today) -- The FDA approved venglustat (Infilbray) tablets as the first treatment for neurologic symptoms of type 3 Gaucher disease in adults and children weighing at least 15 kg, the agency announced Wednesday. Gaucher disease is a rare...

  2. Ibtimes Center Factuality: Mostly factual GB
    FDA Approves Sanofi's Infilbray, First Drug to Cross Into Brain for Rare Type 3 Gaucher Disease

    The FDA has approved Sanofi's oral drug Infilbray for adults and children weighing at least 15 kilograms with type 3 Gaucher disease neurological symptoms.

Comments

Comments need JavaScript.